A case of levetiracetam induced bullous pemphigoid


Karadag A. S., Güneş Bilgili S., Calka O., Onder S., Kosem M., Burakgazi-Dalkilic E.

CUTANEOUS AND OCULAR TOXICOLOGY, vol.32, no.2, pp.176-178, 2013 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 32 Issue: 2
  • Publication Date: 2013
  • Doi Number: 10.3109/15569527.2012.725444
  • Journal Name: CUTANEOUS AND OCULAR TOXICOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.176-178
  • Van Yüzüncü Yıl University Affiliated: Yes

Abstract

Bullous pemphigoid is a chronic, acquired autoimmune skin disease. Certain drugs such as furosemide, penicillins, sulfonamides, ciprofloxacins, penicillamines, angiotensin converting enzyme inhibitors, chloroquine, and phenacetin were reported to cause bullous pemphigoid. This is a case report of a 70-year-old female, who presented with the formation of diffuse cutaneous blister in month after starting to use levetiracetam. Dermatological exam and histopathological findings were consistent with bullous pemphigoid. To the best of our knowledge this is the first case of bullous pemphigoid in the literature associated with levetiracetam use.